| DIRECT COMPETITOR COMPARISON | |
| SYMBA.OB | VIFL | STE | Pvt1 | Industry | | Market Cap: | 824.19K | 4.92M | 1.66B | N/A | 70.20M | | Employees: | 1 | 13 | 5,000 | 2691 | 43 | | Qtrly Rev Growth (yoy): | N/A | -19.90% | -2.80% | N/A | 3.00% | | Revenue (ttm): | 32.66K | 2.52M | 1.26B | 80.80M1 | 17.49M | | Gross Margin (ttm): | 1.48% | 77.89% | 41.33% | N/A | 71.29% | | EBITDA (ttm): | -594.93K | 942.97K | 248.52M | N/A | -6.12M | | Oper Margins (ttm): | -1,905.67% | 21.91% | 15.18% | N/A | -3.79% | | Net Income (ttm): | -621.54K | 1.33M | 113.98M | N/A | N/A | | EPS (ttm): | -0.032 | 0.474 | 1.927 | N/A | -0.19 | | P/E (ttm): | N/A | 3.78 | 14.71 | N/A | 16.51 | | PEG (5 yr expected): | N/A | N/A | 0.98 | N/A | 1.30 | | P/S (ttm): | 22.71 | 1.96 | 1.32 | N/A | 3.36 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.86 | 0.98% | 57.55B | 12.40 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.87 | 0.45% | 14.13B | 16.36 | | Genzyme Corp. | GENZ | 49.98 | 0.48% | 13.26B | 28.49 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.96 | 1.16% | 42.26B | 18.16 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.62 | 2.69% | 9.21B | 1053.47 | | Teva Pharmaceutical Industries Limited | TEVA | 53.49 | 1.33% | 47.12B | 48.94 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 38.65 | 0.97% | 4.10B | 19.92 | | King Pharmaceuticals Inc. | KG | 11.84 | 1.98% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.77 | 1.35% | 5.74B | 115.15 | | Pfizer Inc. | PFE | 18.40 | 0.55% | 148.48B | 15.28 | | Johnson & Johnson | JNJ | 64.96 | 0.17% | 179.23B | 14.19 | | GlaxoSmithKline plc | GSK | 42.91 | 1.59% | 108.78B | 13.80 | | Sanofi-Aventis | SNY | 38.76 | 0.68% | 101.21B | N/A | | Novartis AG | NVS | 54.21 | 0.71% | 123.12B | 16.23 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.00 | 0.61% | N/A | N/A | | AstraZeneca plc | AZN | 45.78 | 0.22% | 66.38B | 9.19 | | Abbott Laboratories | ABT | 53.78 | 0.02% | 83.18B | 14.57 | | Bristol-Myers Squibb Co. | BMY | 25.96 | 0.62% | 51.43B | 13.43 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | STE | | [$$] DirectTV: The Picture Brightens
Sat, Dec 12 -
at Barrons.com | | • | STE | | STERIS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mon, Dec 7 -
EDGAR Online | | • | STE | | F.D.A. Warns of Problems With Sterilization Device
Sat, Dec 5 -
at The New York Times | | • | STE | | Shares of Steris Corp. Plunge on FDA Notice
Fri, Dec 4 -
at Fox Business | | • | STE | | Monster, DuPont, Take-Two are big movers
Fri, Dec 4 -
AP | | • | VIFL | | FOOD TECHNOLOGY SERVICE INC Files SEC form 10-Q, Quarterly Report
Fri, Nov 13 -
EDGAR Online | | • | VIFL | | Food Technology Service, Inc. Reports Earnings
Fri, Nov 13 -
Business Wire | | • | VIFL | | FOOD TECHNOLOGY SERVICE INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant
Tue, Oct 13 -
EDGAR Online | | • | VIFL | | FOOD TECHNOLOGY SERVICE INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant
Tue, Oct 6 -
EDGAR Online | | • | VIFL | | FOOD TECHNOLOGY SERVICE INC Financials
Wed, Aug 26 -
EDGAR Online Financials | | | All Headlines for these symbols... |
|
|
|
0.28% Nasdaq 
Competitors
